Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 31926 - 31950 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Cisplatin	Approved Investigational	PMAIP1	5366	downregulated	Cisplatin results in decreased expression of PMAIP1 mRNA	18q21.32	A20427
Cisplatin	Approved Investigational	PMAIP1	5366	upregulated	Cisplatin results in increased expression of PMAIP1 mRNA	18q21.32	A22204 A22212 A22211 A22224
Cisplatin	Approved Investigational	PMEPA1	56937	upregulated	Cisplatin results in increased expression of PMEPA1 mRNA	20q13.31	A20427
Cisplatin	Approved Investigational	POLM	27434	upregulated	Cisplatin results in increased expression of POLM mRNA	7p13	A20660
Cisplatin	Approved Investigational	POLR3F	10621	downregulated	Cisplatin results in decreased expression of POLR3F mRNA	20p11.23	A20427
Cisplatin	Approved Investigational	POLR3G	10622	downregulated	Cisplatin results in decreased expression of POLR3G mRNA	5q14.3	A22203
Cisplatin	Approved Investigational	POU5F1	5460	upregulated	[Cisplatin results in decreased susceptibility to Cisplatin] which results in increased expression of POU5F1 mRNA	6p21.33	A22232
Cisplatin	Approved Investigational	POU5F1	5460	upregulated	Cisplatin results in increased expression of POU5F1 mRNA	6p21.33	A22239
Cisplatin	Approved Investigational	PPARA	5465	downregulated	Cisplatin results in decreased expression of PPARA mRNA	22q13.31	A22205
Cisplatin	Approved Investigational	PPFIBP1	8496	upregulated	Cisplatin results in increased expression of PPFIBP1 mRNA	12p11.23, 12p11.22	A20427
Cisplatin	Approved Investigational	PPIF	10105	upregulated	Cisplatin results in increased expression of PPIF mRNA	10q22.3	A22204
Cisplatin	Approved Investigational	PPIG	9360	downregulated	Cisplatin results in decreased expression of PPIG mRNA	2q31.1	A20427
Cisplatin	Approved Investigational	PPM1D	8493	upregulated	Cisplatin results in increased expression of PPM1D mRNA	17q23.3	A22212 A21978 A22203
Cisplatin	Approved Investigational	PPP4R2	151987	downregulated	Cisplatin results in decreased expression of PPP4R2 mRNA	3p13	A20427
Cisplatin	Approved Investigational	PRC1	9055	upregulated	Cisplatin results in increased expression of PRC1 mRNA	15q26.1	A20427
Cisplatin	Approved Investigational	PRDM1	639	downregulated	Cisplatin results in decreased expression of PRDM1 mRNA	6q21	A20427
Cisplatin	Approved Investigational	PRDM1	639	upregulated	Cisplatin results in increased expression of PRDM1 mRNA	6q21	A22212
Cisplatin	Approved Investigational	PRICKLE1	144165	downregulated	Cisplatin results in decreased expression of PRICKLE1 mRNA	12q12	A22204
Cisplatin	Approved Investigational	PRIM2	5558	downregulated	Cisplatin results in decreased expression of PRIM2 mRNA	6p11.2	A22204
Cisplatin	Approved Investigational	PRKAA1	5562	upregulated	Cisplatin results in increased expression of PRKAA1 mRNA	5p13.1	A22204
Cisplatin	Approved Investigational	PRKAB1	5564	upregulated	Cisplatin results in increased expression of PRKAB1 mRNA	12q24.23	A22212 A20427
Cisplatin	Approved Investigational	PRKAB2	5565	downregulated	Cisplatin results in decreased expression of PRKAB2 mRNA	1q21.1	A20427
Cisplatin	Approved Investigational	PRKAR1A	5573	downregulated	Cisplatin results in decreased expression of PRKAR1A mRNA	17q24.2	A22205
Cisplatin	Approved Investigational	PRKCA	5578	downregulated	Cisplatin results in decreased expression of PRKCA mRNA	17q24.2	A22204 A22205
Cisplatin	Approved Investigational	PRKDC	5591	upregulated	Cisplatin results in increased expression of PRKDC mRNA	8q11.21	A22205

Displaying entries 31926 - 31950 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability